Form 8-K Axogen, Inc. For: Feb 25

Go back to Form 8-K Axogen, Inc. For: Feb 25

AxoGen, Inc. (AXGN) PT Raised to $26 at Canaccord Genuity

February 25, 2025 4:39 PM EST

Canaccord Genuity analyst Kyle Rose raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $26.00 (from $22.00) while maintaining a Buy rating.

The analyst commented, "AXGN posted strong Q4 results, beating top- and bottom-line expectations while again generating cash flow. AXGN notes its positive performance reflects ongoing... More

AxoGen, Inc. (AXGN) PT Raised to $25 at Raymond James

February 25, 2025 4:00 PM EST

Raymond James analyst Jayson Bedford raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $23.00) while maintaining a Outperform rating.

The analyst comments "AXGNs initial 2025 guidance was well above our expectation and the investor day preview (highlighted by an expectation of... More

AxoGen, Inc. (AXGN) PT Raised to $25 at Leerink Partners

February 25, 2025 1:07 PM EST

Leerink Partners analyst Mike Kratky raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $18.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: We are reiterating our Outperform rating on AXGN and increasing our PT to $25 (from $18) following the company's 4Q24 earnings. Consistent with its preannouncement (see HERE),... More